Search results
Results from the WOW.Com Content Network
The former Merck & Co. headquarters building is a modernist office building located in the Whitehouse Station section of Readington Township, New Jersey, United States. [4] It was designed by Kevin Roche John Dinkeloo and Associates, LLC in the late 1980s for the Merck & Co. pharmaceutical company. [ 5 ]
Merck Headquarters Building, the former headquarters of Merck & Co. in Whitehouse Station, New Jersey, United States Topics referred to by the same term This disambiguation page lists articles associated with the title Merck headquarters .
The Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt, with about 60,000 employees and a presence in 66 countries. The group includes around 250 companies; the main company is Merck KGaA in Germany. The company is divided into three business lines: Healthcare ...
Merck Updates Plans for Headquarters Move in New Jersey Company to Close Summit Campus; Move Global HQ to Kenilworth WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck (NYS: MRK) , known as MSD ...
For premium support please call: 800-290-4726 more ways to reach us
Merck & Co. traces its origins to its former German parent company Merck Group, which was established by the Merck family in 1668 when Friedrich Jacob Merck purchased a drug store in Darmstadt. [ 27 ] [ 28 ] In 1827, Merck Group evolved from a pharmacy to a drug manufacturer company with the commercial manufacture of morphine . [ 29 ]
The company was established in the 1950s as a division of Hoechst (now Sanofi). [2] The name of the company is derived from the organic compound diazo. [3] In 1997 it was acquired by Clariant, a Swiss specialty chemicals business and in 2004 it was bought with funds controlled by the Carlyle Group. [2]
2014 – Merck KGaA announced that it would purchase Sigma-Aldrich for approx. $17 billion (€13.1 billion). [16] [17] November 3, 2014 – Sigma-Aldrich filed a definitive proxy statement with the U.S. Securities and Exchange Commission to hold a special investors meeting regarding approval for the sale to Merck KGaA. [18]